Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway–Dependent Apoptosis
Xuemei Xie(The University of Texas MD Anderson Cancer Center), Naoto T. Ueno(Breast Cancer Care)
Cited by 33
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
|Journal of Clinical Oncology|1998|927
A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer
|Molecular Endocrinology|2010|232